Losing the Humanity of Transplants

January 18, 2019

In December, the FDA approved a small trial in Boston to graft genetically modified pig skin onto human burn victims. It’s a small step for what is called xenotransplantation (transplanting from one species to another). The trial doesn’t involve an internal organ, and the grafts are meant to be temporary. But it is the first FDA approval since the profession imposed a moratorium on itself 20 years ago, and it comes from advances in gene-editing technology, which suggests that more such efforts are on the way.

Contact Us

359 Newbury Street, 5th Floor Suite 526

Boston, MA 02115

617-939-7892

info@xenotherapeutics.org

Connect with us
SUBSCRIBE

Federal EIN Number: 81-1016095

© 2020 by XenoTherapeutics Foundation

  • Black Facebook Icon
  • Black Twitter Icon
  • LinkedIn